These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 2822930
1. Structure-activity relationships of cyclic opioid peptide analogues containing a phenylalanine residue in the 3-position. Schiller PW, Nguyen TM, Maziak LA, Wilkes BC, Lemieux C. J Med Chem; 1987 Nov; 30(11):2094-9. PubMed ID: 2822930 [Abstract] [Full Text] [Related]
2. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity. Schiller PW, Weltrowska G, Nguyen TM, Lemieux C, Chung NN, Marsden BJ, Wilkes BC. J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045 [Abstract] [Full Text] [Related]
7. The mu- and delta-opioid pharmacophore conformations of cyclic beta-casomorphin analogues indicate docking of the Phe3 residue to different domains of the opioid receptors. Brandt W, Stoldt M, Schinke H. J Comput Aided Mol Des; 1996 Jun; 10(3):201-12. PubMed ID: 8808737 [Abstract] [Full Text] [Related]
9. 14-membered cyclic opioids related to dermorphin and their partially retro-inverso modified analogues. I. Synthesis and biological activity. Said-Nejad OE, Felder ER, Mierke DF, Yamazaki T, Schiller PW, Goodman M. Int J Pept Protein Res; 1992 Feb; 39(2):145-60. PubMed ID: 1517014 [Abstract] [Full Text] [Related]
10. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity. Heyl DL, Schmitter SJ, Bouzit H, Johnson TW, Hepp AM, Kurtz KR, Mousigian C. Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499 [Abstract] [Full Text] [Related]
11. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity. Mosberg HI, Heyl DL, Haaseth RC, Omnaas JR, Medzihradsky F, Smith CB. Mol Pharmacol; 1990 Dec; 38(6):924-8. PubMed ID: 2174509 [Abstract] [Full Text] [Related]
15. Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors. Kazmierski W, Wire WS, Lui GK, Knapp RJ, Shook JE, Burks TF, Yamamura HI, Hruby VJ. J Med Chem; 1988 Nov; 31(11):2170-7. PubMed ID: 2903246 [Abstract] [Full Text] [Related]
19. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor. Charpentier S, Sagan S, Delfour A, Nicolas P. Biochem Biophys Res Commun; 1991 Sep 30; 179(3):1161-8. PubMed ID: 1656944 [Abstract] [Full Text] [Related]
20. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens. Sagan S, Corbett AD, Amiche M, Delfour A, Nicolas P, Kosterlitz HW. Br J Pharmacol; 1991 Oct 30; 104(2):428-32. PubMed ID: 1665735 [Abstract] [Full Text] [Related] Page: [Next] [New Search]